Yini Xu Selected Research

Yini Xu Research Topics

Disease

6	Fibrosis (Cirrhosis) 07/2019 - 03/2012
5	Myocardial Infarction 12/2018 - 03/2012
3	Neoplasms (Cancer) 01/2021 - 01/2019
2	Infections 04/2021 - 12/2019
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 11/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 10/2017
1	Adenoviridae Infections (Adenovirus Infections) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Gliosis 01/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020
1	Diabetic Cardiomyopathies 01/2020
1	Diabetes Complications 01/2020
1	Bacterial Infections (Bacterial Infection) 03/2019
1	Carcinogenesis 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Cicatrix (Scar) 12/2018
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/2017
1	Hypertension (High Blood Pressure) 11/2017
1	Diabetes Mellitus 10/2017
1	Heart Failure 10/2017
1	Infarction (Infarctions) 08/2015
1	Vascular System Injuries 11/2014
1	Atherosclerosis 01/2014

Drug/Important Bio-Agent (IBA)

4	oxymatrineIBA 01/2021 - 03/2012
3	Anti-Infective Agents (Microbicides)IBA 04/2021 - 03/2019
3	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	Volatile Oils (Essential Oils)IBA 01/2020 - 10/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 11/2019
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2015 - 03/2012
2	oxidized low density lipoproteinIBA 11/2014 - 01/2014
2	Messenger RNA (mRNA)IBA 01/2014 - 03/2012
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	cyclovirobuxine DIBA 01/2020
1	AntioxidantsIBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	CurcuminIBA 07/2019
1	AldosteroneIBA 07/2019
1	SilverIBA 03/2019
1	baicaleinIBA 01/2019
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Fibronectins (Fibronectin)IBA 01/2019
1	FlavonoidsIBA 01/2019
1	VimentinIBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	Extracellular Matrix ProteinsIBA 01/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019
1	Autophagy-Related ProteinsIBA 12/2018
1	Toll-Like Receptor 4IBA 12/2018
1	Angiotensin IIIBA 10/2018
1	prolinedithiocarbamate (PDTC)IBA 10/2018
1	salvianolic acid BIBA 10/2018
1	Annexin A5IBA 11/2017
1	Glucose (Dextrose)FDA LinkGeneric 10/2017
1	pyrazolanthroneIBA 10/2017
1	Collagen Type III (Type III Collagen)IBA 10/2017
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 10/2017
1	SB 203580IBA 10/2017
1	AlkaloidsIBA 07/2016
1	Collagen Type I (Type I Collagen)IBA 08/2015
1	Ginkgo biloba extract (Rokan)IBA 08/2015
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 08/2015
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2015
1	Captopril (Capoten)FDA LinkGeneric 08/2015
1	salicylhydroxamic acid (SHAM)IBA 08/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2014
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2012

Therapy/Procedure

3	Therapeutics 01/2021 - 10/2017
3	Ligation 10/2017 - 03/2012
1	Drug Therapy (Chemotherapy) 01/2021